About

 

Board members

Povl-Andre Bendz

Chairman

Povl-Andre Bendz (1962) is an Executive and Investor. Povl-Andre has an M.Sc. from Copenhagen Business School and long experience from commercial and financial assignments. Povl-Andre has previously been CEO and owner at Upfront Chromatography for 3 years, Executive Vice President and CFO at the Danish company Delta Technology for nine years and has long experience of board work. Povl-André has been the chairman of 2cureX AB since 2017 and 2cureX A/S since 2014. Povl-Andre is independent against both company and major owners.

2cureX share ownership
51 282 shares via own company
Other board assignments
Agilco Aps
Upfront Chromatography A/S
UpLix P/S
2cureX warrant ownership
62 526

Jørgen Drejer

Board Member

Jørgen Drejer (1955) is the CEO and principal owner of the listed company Saniona AB. Jørgen is an experienced entrepreneur and has previously founded a large number of biotech companies, including NsGene and Sophion Biosciences. Jørgen is a member of the Danish Academy of Engineering Sciences and has also been a director of the Danish Research Council for Independent Research. Jørgen holds a doctorate in neurobiology from Copenhagen University and is the author of more than 75 scientific articles. Jørgen has been a board member of 2cureX AB since 2017 and 2cureX A/S since 2017. Jørgen is independent against both company and major owners.

2cureX share ownership
12 820 shares
Other board assignments
Azign Bioscience A/S
Saniona AB
Ellegaard Göttingen Minipigs A/S
2cureX warrant ownership
30 905

Camilla Huse Bondesson

Board Member

Camilla Huse Bondesson, born 1958, is a well-experienced member of the board within the field of medicine and biotechnology. Camilla Huse Bondesson has an Executive MBA from Stockholm University. Currently, Camilla Huse Bondesson is Chairman of the Board of Gradientech AB, Immuneed AB and TdB Consultancy AB. Camilla Huse Bondesson also has over thirty years of international operational experience from senior positions at companies in medicine and biotechnology, including as General Manager of Behring Diagnostica AB, International Product Manager for Biacore, Marketing Director of Amersham Biosciences (current GE Healthcare Life Sciences) and VP Marketing for Gyros AB. Since 2004 is Camilla Huse Bondesson working as a consultant and partner at Conlega AB, a consulting company focused on Life Science.

2cureX share ownership
33 472 shares
Other board assignments
Gradientech AB
Immuneed AB
TdB Consultancy AB

Timm Jessen

Board Member

Timm Jessen (1962) is a co-founder of 2cureX and has been a board member of 2cureX since 2006. Timm is co-founder and CEO of Topas Therapeutics. Timm started his commercial career in Hoechst AG, where he was a member of the company's management and strategy team. Timm has also served as CSO and COO for EcotecOAI, where he played an important role in the company's strategic decision to initiate drug development programs. Timm is independent against both company and major owners.

2cureX share ownership
583 902 shares
Other board assignments
Topas Theraoeutics GmbH

Ole Thastrup

Board Member

Ole Thastrup (1953) is co-founder and CEO of 2cureX. He has been a board member of 2cureX since 2006. Ole is also Professor at the University of Copenhagen. Prior to 2cureX Ole was Head of Carlsberg Biosector where he was responsible for Carlsberg's biomedical research. Before that, Ole was the scientific founder and Chief Scientific Officer of BioImage A/S (now Thermo Fischer BioImage) that was spun out of Novo Nordisk A/S. Ole is dependent against the company but independent against major owners.

2cureX share ownership
3 778 304 shares via own company
Other board assignments
OT311 ApS


Subscription for 2cureX News and Press Releases

Language News type
Your information

Data storage policy

Contact information

2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail: info@2curex.com

Privacy Policy | Imprint